ALEO2 Fundamental Analysis - EO2

Fundamental Rating

Taking everything into account, ALEO2 scores 2 out of 10 in our fundamental rating. ALEO2 was compared to 63 industry peers in the Oil, Gas & Consumable Fuels industry. ALEO2 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALEO2 has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALEO2 had positive earnings in the past year.

ALEO2 had a negative operating cash flow in the past year.

ALEO2 had positive earnings in each of the past 5 years.

Of the past 5 years ALEO2 4 years had a positive operating cash flow.

1.2 Ratios

ALEO2 has a Return On Assets of 1.60%. This is in the lower half of the industry: ALEO2 underperforms 73.44% of its industry peers.

Looking at the Return On Equity, with a value of 3.48%, ALEO2 is doing worse than 73.44% of the companies in the same industry.

The Return On Invested Capital of ALEO2 (0.74%) is worse than 79.69% of its industry peers.

The Average Return On Invested Capital over the past 3 years for ALEO2 is significantly below the industry average of 9.83%.

		Industry Rank	Sector Rank
ROA	1.6%
ROE	3.48%
ROIC	0.74%

ROA(3y)4.32%

ROA(5y)3.34%

ROE(3y)9.77%

ROE(5y)7.71%

ROIC(3y)4.43%

ROIC(5y)3.25%

1.3 Margins

Looking at the Profit Margin, with a value of 2.08%, ALEO2 is doing worse than 71.88% of the companies in the same industry.

In the last couple of years the Profit Margin of ALEO2 has declined.

ALEO2 has a Operating Margin of 1.19%. This is in the lower half of the industry: ALEO2 underperforms 78.13% of its industry peers.

ALEO2's Operating Margin has declined in the last couple of years.

ALEO2 has a Gross Margin of 42.46%. This is comparable to the rest of the industry: ALEO2 outperforms 50.00% of its industry peers.

In the last couple of years the Gross Margin of ALEO2 has grown nicely.

		Industry Rank	Sector Rank
OM	1.19%
PM (TTM)	2.08%
GM	42.46%

OM growth 3Y-4.51%

OM growth 5Y-16.63%

PM growth 3Y23.02%

PM growth 5Y-5.38%

GM growth 3Y25.04%

GM growth 5Y9.23%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALEO2 is destroying value.

Compared to 1 year ago, ALEO2 has less shares outstanding

The number of shares outstanding for ALEO2 has been reduced compared to 5 years ago.

The debt/assets ratio for ALEO2 is higher compared to a year ago.

2.2 Solvency

ALEO2 has an Altman-Z score of 1.74. This is a bad value and indicates that ALEO2 is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of ALEO2 (1.74) is comparable to the rest of the industry.

ALEO2 has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.50, ALEO2 is in line with its industry, outperforming 48.44% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	N/A
Altman-Z	1.74

ROIC/WACC0.12

WACC6.37%

2.3 Liquidity

ALEO2 has a Current Ratio of 2.59. This indicates that ALEO2 is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of ALEO2 (2.59) is better than 84.38% of its industry peers.

ALEO2 has a Quick Ratio of 1.80. This is a normal value and indicates that ALEO2 is financially healthy and should not expect problems in meeting its short term obligations.

ALEO2's Quick ratio of 1.80 is fine compared to the rest of the industry. ALEO2 outperforms 75.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.59
Quick Ratio	1.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALEO2 have decreased strongly by -96.09% in the last year.

Measured over the past 5 years, ALEO2 shows a small growth in Earnings Per Share. The EPS has been growing by 0.52% on average per year.

Looking at the last year, ALEO2 shows a very negative growth in Revenue. The Revenue has decreased by -31.55% in the last year.

ALEO2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.99% yearly.

EPS 1Y (TTM)-96.09%

EPS 3Y35.45%

EPS 5Y0.52%

EPS Q2Q%-58.53%

Revenue 1Y (TTM)-31.55%

Revenue growth 3Y11.24%

Revenue growth 5Y5.99%

Sales Q2Q%-17.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 38.86, which means the current valuation is very expensive for ALEO2.

71.88% of the companies in the same industry are cheaper than ALEO2, based on the Price/Earnings ratio.

ALEO2's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.06.

		Industry Rank	Sector Rank
PE	38.86
Fwd PE	N/A

4.2 Price Multiples

60.94% of the companies in the same industry are more expensive than ALEO2, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	5.36

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)74.07

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALEO2!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EO2

EPA:ALEO2 (9/5/2025, 7:00:00 PM)

2.72

0 (0%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners28.33%

Ins Owner ChangeN/A

Market Cap6.53M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	38.86
Fwd PE	N/A
P/S	0.19
P/FCF	N/A
P/OCF	N/A
P/B	0.32
P/tB	0.35
EV/EBITDA	5.36

EPS(TTM)0.07

EY2.57%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-2.82

FCFYN/A

OCF(TTM)-1.1

OCFYN/A

SpS14.2

BVpS8.5

TBVpS7.82

PEG (NY)N/A

PEG (5Y)74.07

Profitability

		Industry Rank	Sector Rank
ROA	1.6%
ROE	3.48%
ROCE	1.14%
ROIC	0.74%
ROICexc	0.93%
ROICexgc	0.98%
OM	1.19%
PM (TTM)	2.08%
GM	42.46%
FCFM	N/A

ROA(3y)4.32%

ROA(5y)3.34%

ROE(3y)9.77%

ROE(5y)7.71%

ROIC(3y)4.43%

ROIC(5y)3.25%

ROICexc(3y)7.15%

ROICexc(5y)5.22%

ROICexgc(3y)7.62%

ROICexgc(5y)5.52%

ROCE(3y)6.78%

ROCE(5y)4.98%

ROICexcg growth 3Y-0.06%

ROICexcg growth 5Y-15.64%

ROICexc growth 3Y-0.72%

ROICexc growth 5Y-16.61%

OM growth 3Y-4.51%

OM growth 5Y-16.63%

PM growth 3Y23.02%

PM growth 5Y-5.38%

GM growth 3Y25.04%

GM growth 5Y9.23%

F-Score3

Asset Turnover0.77

Health

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	N/A
Debt/EBITDA	4.41
Cap/Depr	218.47%
Cap/Sales	12.12%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.59
Quick Ratio	1.8
Altman-Z	1.74

F-Score3

WACC6.37%

ROIC/WACC0.12

Cap/Depr(3y)123.02%

Cap/Depr(5y)99.34%

Cap/Sales(3y)7.35%

Cap/Sales(5y)6.3%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-96.09%

EPS 3Y35.45%

EPS 5Y0.52%

EPS Q2Q%-58.53%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-31.55%

Revenue growth 3Y11.24%

Revenue growth 5Y5.99%

Sales Q2Q%-17.61%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-93.7%

EBIT growth 3Y6.23%

EBIT growth 5Y-11.64%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-264.44%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-147.88%

OCF growth 3YN/A

OCF growth 5YN/A

EO2 (ALEO2.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens